Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [49]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Research works printed but not linked: 1
- el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).
Cited by
Items 101–200 of 548
Ball, K. L., Laín, S., Fåhræus, R., Smythe, C., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00029-7 · Cited by 171
Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21
Coqueret, O., & Gascan, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001601200 · Cited by 152
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
p 21WAF1 C ontrol of E pithelial C ell C ycle and C ell F ate
Weinberg, W. C., & Denning, M. F. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300603 · Cited by 150
Strategies for manipulating the p53 pathway in the treatment of human cancer
Hupp, T. R., Lane, D. P., & Ball, K. L. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520001 · Cited by 148
“147 Wang, Y. and Prives, C. (1995) Increased and altered DNA-binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.”
BackgroundControl of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 188
Both cyclin A and cyclin E have S-phase promoting (SPF) activity in Xenopus egg extracts
Strausfeld, U. P., Howell, M., Descombes, P., Chevalier, S., Rempel, R. E., Adamczewski, J. P., Maller, J. L., Hunt, T., & Blow, J. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1555 · Cited by 143
Draviam, V. M., Orrechia, S., Lowe, M., Pardi, R., & Pines, J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.945 · Cited by 143
“The Journal of Cell Biology, Volume 152, 2001 946 cated the hydrophobic patch in binding to the “Cy motif” (R 3 L) of substrates such as p107 (Zhu et al., 1995), CDK inhibitors such as p21 Cip1/Waf1 and p27 Kip1 (Chen et al., 1995; Russo et al., 1996), and the CDK activator Cdc25A (Saha et al., 1997).”
BackgroundBone marrow cells repair cigarette smoke-induced emphysema in rats
Huh, J. W., Kim, S.-Y., Lee, J. H., Lee, J.-S., Van Ta, Q., Kim, M., Oh, Y.-M., Lee, Y.-S., & Lee, S.-D. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00253.2010 · Cited by 143
Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage
Li, R., Hannon, G. J., Beach, D., & Stillman, B. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00452-9 · Cited by 161
“Recent studies have revealed that different domains of p21 interact with Cdks and PCNA, and that both of these domains can independently inhibit DNA replication when present in cells [35–38].”
Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
Zaman, M. S., Shahryari, V., Deng, G., Thamminana, S., Saini, S., Majid, S., Chang, I., Hirata, H., Ueno, K., Yamamura, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031060 · Cited by 146
“In Western blot experiments we checked CDK4, E1 and E2 as CDK2 is already known to be affected by p21 gene [13,14].”
MethodThe cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus
Vernon, A. E., Devine, C., & Philpott, A. (2003) · Development · doi:10.1242/dev.00193 · Cited by 137
“To address this question we used N- and C-terminal constructs of p21Cip1 [amino acids 1-89 (p21Cip1 NT) and 87- 164 (p21Cip1 CT)], which arrest the cell cycle in distinct ways. p21Cip1 NT blocks cyclin/cdk kinase activity while p21Cip1 CT binds and inactivates PCNA (Chen et al., 1995).”
BackgroundDefect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
Beamish, H., Williams, R., Chen, P., & Lavin, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20486 · Cited by 137
Identification of Two RNA-binding Proteins Associated with Human Telomerase RNA
Le, S., Sternglanz, R., & Greider, C. W. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.999 · Cited by 136
Punchihewa, C., Inoue, A., Hishiki, A., Fujikawa, Y., Connelly, M., Evison, B., Shao, Y., Heath, R., Kuraoka, I., Rodrigues, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353201 · Cited by 135
“T2AA Inhibits PCNA-DNA Polymerase Interaction on Replication Foci in Cells but Does Not Remove Chromatin-bound PCNA—Upon observing that T2AA disrupts PCNA-p21 interaction in vitro, we investigated if T2AA inhibits PCNA interactions in cells, in the same way that p21 does to control the cell cycle (19).”
BackgroundHarris, T. E., Albrecht, J. H., Nakanishi, M., & Darlington, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011587200 · Cited by 133
Suzuki, A., Tsutomi, Y., Yamamoto, N., Shibutani, T., & Akahane, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3842 · Cited by 131
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi-Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 129
Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity
Dash, B. C., & El‐Deiry, W. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3364-3387.2005 · Cited by 160
“Cyclins and CDKs bind p21 through the consensus site CRRL (p21 amino acids [aa] 18 to 21) at the N-terminal end, and this motif is required for inhibition of cell cycle progression (11, 12, 23, 46).”
BackgroundInfluentialDysregulation of cellular signaling by HER2 in breast cancer
Zhou, B. P., & Hung, M.-C. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 149
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T- cell leukemia/lymphoma
Roberta Morosetti, A., Kawamata, N., Gombart, A., Cw, M., Hatta, Y., Hirama, T., Jw, S., Tomonaga, M., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.5.1924.bloodjournal8651924 · Cited by 134
PCNA, a multifunctional ring on DNA
Tsurimoto, T. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00204-8 · Cited by 139
A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Mazumder, S., DuPree, E., & Almasan, A. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481669 · Cited by 148
Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., & Mendelsohn, J. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.235 · Cited by 125
“7 B) was accompanied by a rise and fall in p21Cipl/wgF1 associated PCNA (Fig.”
BackgroundInfluentialInduction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El-Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 126
“cdk complexes associated with p21 can retain catalytic activity, typically at low inhibitor stoichiometries (11, 53, 110).”
BackgroundPodust, V. N., Podust, L. M., Goubin, F., Ducommun, B., & Huebscher, U. (1995) · Biochemistry · doi:10.1021/bi00027a039 · Cited by 124
Wu, J., & Lingrel, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207996 · Cited by 128
“…such as p21WAF1/CIP1 (Sherr and Roberts, 1995; Harper and Elledge, 1996; Dynlacht, 1997). p21WAF1/CIP1, a transcriptional target of p53 (elDeiry et al., 1993), is a component of a complex containing cyclins, CDKs and proliferating cell nuclear antigen (Zhang et al., 1993; Chen et al., 1995).”
BackgroundRomanov, V. S., Pospelov, V. A., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 123
Chen, U., Chen, S., Saha, P., & Dutta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11597 · Cited by 121
Self-citationCyclin E Uses Cdc6 as a Chromatin-Associated Receptor Required for DNA Replication
Furstenthal, L., Kaiser, B. K., Swanson, C. A., & Jackson, P. K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1267 · Cited by 122
“amino acids 1–90; p21C, amino acids 87–164 (Chen et al., 1995); and”
BackgroundMethodSelf-citationExpression of Geminin as a Marker of Cell Proliferation in Normal Tissues and Malignancies
Wohlschlegel, J. A., Kutok, J. L., Weng, A. P., & Dutta, A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64178-8 · Cited by 120
“As a positive control, we overexpressed the N terminal half of p21 (p21N) that is known to interact with and inhibit cyclindependent kinases.(19) p21N strongly blocks cells in G1 phase of the cell cycle as seen in Figure 6B.”
Self-citationHu, J., & Xiong, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500464200 · Cited by 118
Prosperi, E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_15 · Cited by 128
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202681 · Cited by 133
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan, K. L., Jenkins, C. W., Li, Y., O'Keefe, C. L., Noh, S., Wu, X., Zariwala, M., Matera, A. G., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.57 · Cited by 118
Nishio, K., Inoue, A., Qiao, S., Kondo, H., & Mimura, A. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100325 · Cited by 115
“The senescent cells have specific characters such as enlarged cell shapes, a shortened telomere (Allsopp et al. 1992), and high expression levels of the cell cycle inhibitor SDI1 (Noda et al. 1994), which inhibits cdk2 kinase and PCNA ( Chen et al. 1995 ).”
BackgroundCDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
Koenig, A., Bianco, S. R., Fosmire, S. P., Wojcieszyn, J. W., & Modiano, J. F. (2002) · Veterinary Pathology · doi:10.1354/vp.39-4-458 · Cited by 129
Ducoux, M., Urbach, S., Baldacci, G., Hübscher, U., Koundrioukoff, S., Christensen, J., & Hughes, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106990200 · Cited by 111
Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities
Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111
“The p21 protein has also been shown to bind to PCNA (3, 44).”
BackgroundSeresht, H. R., Cheshomi, H., Falanji, F., Motlagh, F. M., Hashemian, M., & Mireskandari, E. (2019) · PubMed Central · doi:10.22038/ajp.2019.13475 · Cited by 129
“P21 can also bind proliferating cell nuclear antigen (PCNA), thereby directly preventing DNA synthesis (Chen et al., 1995).”
Backgroundp21CIP1 and Cdc25A: Competition between an Inhibitor and an Activator of Cyclin-Dependent Kinases
Saha, P., Eichbaum, Q., Silberman, E. D., Mayer, B. J., & Dutta, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4338 · Cited by 108
“However, the cdk inhibitory activity, rather than the proliferating cell nuclear antigen binding activity, is required to block G1-S transition (4, 26).”
BackgroundMethodInfluentialSelf-citationComplete inhibition of Cdk/cyclin by one molecule of p21Cip1
Hengst, L., Göpfert, U., Lashuel, H. A., & Reed, S. I. (1998) · Genes & Development · doi:10.1101/gad.12.24.3882 · Cited by 107
“It has been shown that the amino-terminal domains of both proteins are sufficient for Cdk inhibition (Toyoshima and Hunter 1994; Chen et al. 1995; Luo et al. 1995).”
BackgroundShankland, S. J., Hugo, C., Coats, S. R., Nangaku, M., Pichler, R. H., GORDON, K. L., Pippin, J. W., Roberts, J. M., Couser, W. G., & Johnson, R. J. (1996) · Kidney International · doi:10.1038/ki.1996.432 · Cited by 106
Graves, T. G., Harr, M. W., Crawford, E. L., & Willey, J. C. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-1 · Cited by 112
“In turn, p21 protein interacts with cyclin-cdk complexes [14-16], associates with pRb protein [17], PCNA [18-20], GADD45 [21,22], cooperates with 14-3-3 [23], and/or modulates the activities of DNA polymerase δ [24].”
InfluentialScott, M. T., MORRICE, N. A., & Ball, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11529 · Cited by 123
Inhibition of Myogenesis by Multiple Cyclin-Cdk Complexes
Guo, K., & Walsh, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.791 · Cited by 105
Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems
Medina, D., & Santisteban, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430161 · Cited by 105
Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.
Su, J. Y., Rempel, R. E., ERIKSON, E., & Maller, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10187 · Cited by 113
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
Greco, O., & Dachs, G. U. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<::aid-jcp1060>3.0.co;2-h · Cited by 273
Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas
Pallante, P., Visone, R., Croce, C. M., & Fusco, A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0217 · Cited by 111
Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation
Tian, J. Q., & Quaroni, A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.6.c1245 · Cited by 110
“The Cdk and PCNA inhibitory activities of p21 are functionally independent and reside in the aminoand carboxy-terminal domains, respectively (5, 26).”
BackgroundMantel, C., Luo, Z., Canfield, J., Braun, S., Deng, C., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.10.3710.bloodjournal88103710 · Cited by 102
Doglioni, C., Pelosio, P., Laurino, L., Macrì, E., Meggiolaro, E., Favretti, F., & Barbareschi, M. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199607)179:3<248::aid-path571>3.0.co;2-6 · Cited by 101
Nishio, K., & Inoue, A. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0766-5 · Cited by 121
“Antibodies Primary antibodies used were: monoclonal antibodies of anti-vimentin clone V9 (MBL Co. Ltd. Japan), antiPCNA clone PC10 (DAKO Japan Co. Ltd.), anti-actin clone AC-40, and anti-b-tubulin clone TUB2.”
BackgroundInfluentialPack, L. R., Daigh, L. H., Chung, M., & Meyer, T. (2021) · Nature Communications · doi:10.1038/s41467-021-23612-z · Cited by 108
Tanaka, H., Yamashita, T., Yachi, K., Fujiwara, T., Yoshikawa, H., & Tohyama, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.010 · Cited by 103
Role of Cyclin-Dependent Kinases and Their Inhibitors in Cellular Differentiation and Development
Chellappan, S., Giordano, A., & Fisher, P. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_4 · Cited by 102
Cell-cycle control and renal disease
Shankland, S. J. (1997) · Kidney International · doi:10.1038/ki.1997.335 · Cited by 103
The human Rad9–Rad1–Hus1 checkpoint complex stimulates flap endonuclease 1
Wang, W., Brandt, P., Rossi, M. L., Lindsey-Boltz, L., Podust, V., Fanning, E., Sancar, A., & Bambara, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407686101 · Cited by 98
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Brooks, G., Poolman, R. A., & Li, J. M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00125-4 · Cited by 113
Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., & Schneider, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4675 · Cited by 82
Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice
Wei, L., Leibowitz, B. J., Wang, X., Epperly, M., Greenberger, J., Zhang, L., & Yu, J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88410 · Cited by 96
“Interestingly, early studies have demonstrated that distinct domains of p21 bind to CDKs and proliferating cell nuclear antigen (PCNA) to regulate the cell cycle and DNA replication and repair, respectively (39, 40).”
BackgroundSoria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
“…al., 1998; Cazzalini et al., 2003) and NER (Bendjennat, 2003; Cooper et al., 1999), many others report little or no effect on DNA replication (Chen et al., 1995; Lin et al., 1996; Luo et al., 1995; Medema et al., 1998; Nakanishi et al., 1995; Ogryzko et al., 1997) and NER (Li et al., 1994;…”
BackgroundInfluentialCheckpoint mechanisms at the intersection between DNA damage and repair
Lazzaro, F., Giannattasio, M., Puddu, F., Granata, M., Pellicioli, A., Plevani, P., & Muzi-Falconi, M. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.022 · Cited by 94
Ledford, A. W., Nelson‐Brantley, J., Kemeny, G., Foreman, T. L., Quaggin, S. E., Igarashi, P., Oberhaus, S. M., Rodova, M., Calvet, J. P., & Heuvel, G. B. V. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0636 · Cited by 105
Expression of apoptosis related proteins in brains of patients with Alzheimer's disease
Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N., & Lubec, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01618-4 · Cited by 91
Ehmann, G. L., McLean, T. I., & Bachenheimer, S. L. (2000) · Virology · doi:10.1006/viro.1999.0147 · Cited by 112
Fotedar, R., Mossi, R., Fitzgerald, P., Rousselle, T., Maga, G., Brickner, H., Messier, H., Kasibhatla, S., Hübscher, U., & Fotedar, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00815.x · Cited by 98
Caspase-Dependent Cdk Activity Is a Requisite Effector of Apoptotic Death Events
Harvey, K. J., Lukovic, D., & Ucker, D. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.59 · Cited by 101
“The cleavage by caspase 3 of p21Cip1/Waf1 at AEEDHVD112LSL results in 14- and 7-kD peptides that separate the NH2-terminal cyclin/Cdk interacting domain from the COOH-terminal PCNA interacting domain (Chen et al., 1995; Adams et al., 1996).”
BackgroundInduction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde
Ji, C., Rouzer, C. A., Marnett, L. J., & Pietenpol, J. A. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1275 · Cited by 100
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 95
Novel targets of Akt, p21, and MDM2
Zhou, B. P., & Hung, M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70128-0 · Cited by 105
Zhu, H., Zhang, L., Wu, S., Teraishi, F., Davis, J. J., Jacob, D., & Fang, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207645 · Cited by 95
“P21 can also directly inhibit DNA synthesis by binding to proliferating cell nuclear antigen (PCNA) (Waga et al., 1994; Chen et al., 1995).”
BackgroundEstanyol, J. M., Jaumot, M., Casanovas, O., Rodriguez-Vilarrupla, A., Agell, N., & Bachs, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33161 · Cited by 88
Schang, L. M., Hossain, A., & Jones, C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3807-3814.1996 · Cited by 93
“Recent studies have demonstrated that the first 90 amino acids of Cip1 can bind cyclindependent kinase-cyclin complexes (6, 39).”
BackgroundNegative regulation of cell growth by TGFβ
Polyák, K. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00009-5 · Cited by 106
Kelly, B. L., Wolfe, K. G., & Roberts, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2535 · Cited by 102
Kamal, Ä., Bharathi, E. V., Ramaiah, M. J., Dastagiri, D., Reddy, J., Viswanath, A., Sultana, F., Pushpavalli, S. N. C. V. L., Pal‐Bhadra, M., Srivastava, H. K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.015 · Cited by 85
Bogdan, J. A., Adams-Burton, C. R., Pedicord, D. L., Sukovich, D. A., Benfield, P. A., Corjay, M. H., Stoltenborg, J. K., & Dicker, I. B. (1998) · Biochemical Journal · doi:10.1042/bj3360471 · Cited by 84
Functional role of p21 during the cellular response to stress.
Gorospe, M., Wang, X., & Holbrook, N. J. (1999) · Europe PMC (PubMed Central) · Cited by 97
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202686 · Cited by 101
“The N terminal residues 1 ± 82 of p21 bind CDKcyclin complexes and inhibit their activity in vitro (Adams et al., 1996; Chen et al., 1995; Fotedar et al., 1996b; Goubin and Ducommun, 1995; Harper et al., 1995; Luo et al., 1995; Nakanishi et al., 1995).”
BackgroundMethodInfluentialLeone, G., DeGregori, J., Jakoi, L., Cook, J. G., & Nevins, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6626 · Cited by 83
p12DOC-1 Is a Novel Cyclin-Dependent Kinase 2-Associated Protein
Shintani, S., Ohyama, H., Zhang, X., McBride, J., Matsuo, K., Tsuji, T., Hu, M. G., Hu, G., Kohno, Y., Lerman, M. I., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6300-6307.2000 · Cited by 83
Wohlschlegel, J. A., Dwyer, B. T., Takeda, D. Y., & Dutta, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.4868-4874.2001 · Cited by 81
“S-transferase (GST) fusion proteins were expressed and purified as before (4, 5).”
BackgroundMethodSelf-citationThe C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
Cooper, M. P., Balajee, A. S., & Bohr, V. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2119 · Cited by 80
“The C terminus of p21 has been shown to bind PCNA (Chen et al., 1995, 1996; Goubin and Ducommun, 1995; Warbrick et al., 1995), and the binding domain is within amino acids 142–163 (Goubin and Ducommun, 1995; Warbrick et al., 1995).”
BackgroundInfluentialChen, J., Peters, R., Saha, P., Lee, P., Theodoras, A., Pagano, M., Wagner, G., & Dutta, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1727 · Cited by 81
Self-citationXiong, Y., Kuppuswamy, D., Li, Y., Livanos, E. M., Hixon, M., White, A., Beach, D., & Tlsty, T. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.999-1008.1996 · Cited by 80
Disorder-function relationships for the cell cycle regulatory proteins p21 and p27
Mitrea, D. M., Yoon, M., Li, O., & Kriwacki, R. W. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0254 · Cited by 85
“, 1994 ; LaBaer et al. , 1997 ; Cheng et al. , 1999 ). Zhang et al. (1994) originally proposed that multiple p21 molecules could bind to Cdk/cyclin complexes, with binding of the fi rst associated with kinase activity and that of others with kinase inhibition. However, the requirement for the binding of multiple p21 m…”
InfluentialCyclin-Dependent Kinase Inhibitor p21 Modulates the DNA Primer-Template Recognition Complex
Waga, S., & Stillman, B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4177 · Cited by 78
Oku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77
“It has been reported that the p21 protein is separable into two domains, and that the N-terminal half binds with CDK/cyclin to inhibit protein kinase activity (Chen et al. 1995; Luo et al. 1995).”
BackgroundGu, M., Lynch, J., & Brecher, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11389 · Cited by 77
Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block
Gottifredi, V., McKinney, K., Poyurovsky, M. V., & Prives, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310373200 · Cited by 76
Ono, T., Kitaura, H., Ugai, H., Murata, T., Yokoyama, K. K., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003031200 · Cited by 88
Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL)
Hatta, Y., & Koeffler, H. (2002) · Leukemia · doi:10.1038/sj.leu.2402458 · Cited by 89
Functional Roles of p12, the Fourth Subunit of Human DNA Polymerase δ
Li, H., Xie, B., Zhou, Y., Rahmeh, A. A., Trusa, S., Zhang, S., Gao, Y., Lee, E. Y. C., & Lee, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600322200 · Cited by 79
Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2
Adkins, J. N., & Lumb, K. J. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10018 · Cited by 75
Carujo, S., Estanyol, J. M., Ejarque, A., Agell, N., Bachs, O., & Pujol, M. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209433 · Cited by 80
“It interacts with cyclins and cdks by two regions located at the NH2-domain of the protein, and as a consequence, inhibits the activity of cyclin-cdk complexes (Chen et al., 1995; Luo et al., 1995; Nakanishi et al., 1995).”
BackgroundCDKS and CKIS: Molecular targets for tissue remodelling
Nabel, E. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd869 · Cited by 83
Carrasco, N., & Huang, Z. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0383221 · Cited by 78
Metadata
- Authors
- Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Nature
- Published
- 1995-03
- Volume
- 374
- Issue
- 6520
- Pages
- 386-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078690152
- Cited by
- 548
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 20
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, WAF1/CIP1, p53, PCNA, proliferating cell nuclear antigen, protein domains, N-terminal domain, C-terminal domain, DNA replication inhibition, cell cycle arrest, growth inhibition, tumour suppressor
- MeSH terms
- Animals, Haplorhini, Binding Sites, Cell Division, Cell Line, Transformed, DNA Replication, Escherichia coli, Humans, Peptide Fragments, Recombinant Fusion Proteins, Simian virus 40, Tumor Cells, Cultured, Xenopus, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Xenopus Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.